1 | Additional Representation Sheet | 22 Jan 1997 |
1 | Examination Report | 22 Jan 1997 |
10 | Authorization Letter | 14 Aug 2013 |
10 | Examination Report | 14 Aug 2013 |
11 | Journal Copy | 24 Dec 2016 |
12 | Certificate | 23 Jan 2017 |
13 | Cover To Cover | 30 Oct 2021 |
2 | Cover To Cover | 22 Jan 1997 |
2 | TM-1 | 22 Jan 1997 |
3 | Examination Report | 22 Jan 1997 |
3 | Hearing Notice | 22 Jan 1997 |
4 | Additional Representation Sheet | 22 Jan 1997 |
4 | Hearing Notice | 22 Jan 1997 |
5 | Cover To Cover | 22 Jan 1997 |
5 | TM-1 | 22 Jan 1997 |
6 | TM-1 | 29 Jan 1997 |
7 | Other Documents | 29 Jan 1997 |
8 | Note Sheet | 17 Jun 2009 |
9 | Authorization Letter | 14 Aug 2013 |
9 | Examination Report | 14 Aug 2013 |
1 | Hearing Notice for : 731114 | 853576 | 623507 | 15 Jul 2013 |
2 | Tribunal ABA Notice for : 731114 | 881419 | 645901 | 14 Aug 2013 |
The application for Fibadiet was made on 22 January 1997.
The trademark applicant for Fibadiet is GLAXOSMITHKLINE PHARMACEUTICALS.
Fibadiet is applied in class(es) 5.
Application for Fibadiet is on Registered stage.
Application Id allotted to Fibadiet is 731114.
Fibadiet filed with the Intellectual property office as a WORD.